Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Journal of Business News.
BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biohaven Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire, Inc.
·
August 11, 2025
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Biohaven Ltd. (“Biohaven” or “the...
Lynch Carpenter Investigates Claims in Nova Recovery Center Data Breach
GlobeNewswire, Inc.
·
August 11, 2025
PITTSBURGH, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Nova Recovery LLC d/b/a Nova Recovery Center (“Nova Recovery”) recently announced a cybersecurity incident, which impacted the personal information of nearly eight thousand individuals.1 The...
LAOIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Western Asset Management Company, LLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire, Inc.
·
August 11, 2025
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Western Asset Management Company, LLC (“WAMCO” or the...
Fortifi Capital Surpasses $175 Million in Small Business Funding as It Marks Two-Year Anniversary
EIN Presswire
·
August 11, 2025
Fortifi Capital Surpasses $175 Million in Funding, Celebrates Two Years of Empowering Small Businesses with Flexible Financing Solutions NY, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- Fortifi Capital Surpasses $175 Million in Small...
BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition
GlobeNewswire, Inc.
·
August 11, 2025
Business combination transaction with Helix Acquisition Corp. II, a special purpose acquisition company sponsored by affiliates of Cormorant Asset Management, completed on August 11, 2025 Closed concurrent $261 million private investment in public...
NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire, Inc.
·
August 11, 2025
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Novo Nordisk A/S (“Novo Nordisk” or...
Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion
GlobeNewswire, Inc.
·
August 11, 2025
WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), reiterates investor confidence and estimated asset value over $10 billion. In October 2024, HMP Partners and The Patel Family...
Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire, Inc.
·
August 11, 2025
Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in China Granted orphan drug designation from the European Medicines Agency (EMA) for amezalpat for the treatment of...
FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire, Inc.
·
August 11, 2025
Total consideration for the sale of FibroGen China to AstraZeneca now expected to be approximately $210 million, a $50 million increase from initial guidance Net cash held in China at closing now estimated to be approximately $125 million...
Capricor Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
·
August 11, 2025
Type A meeting with U.S. FDA scheduled to discuss Deramiocel BLA and path toward potential approval Capricor seeks to resubmit its BLA based on its existing dataset, with HOPE-3 data (expected in Q4 2025) potentially serving as supportive and...
Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results
GlobeNewswire, Inc.
·
August 11, 2025
Advancing Selection of Next-Generation Oral Small Molecule PTH1R Agonist for Clinical Development Initiating Phase 1 Trial for SEP-631, MRGPRX2 NAM Program, for Mast Cell Diseases Updated Cash Runway Expected to Support Operating Plans at Least...
Gyre Therapeutics Reports Second Quarter 2025 and Year-to-Date Financial Results and Provides Business and Leadership Update
GlobeNewswire, Inc.
·
August 11, 2025
Net income of $1.6 million and $5.3 million for the three and six months ended June 30, 2025, respectively; reaffirms full-year revenue guidance of $118-128 million Ping Zhang, Executive Chairman, appointed interim CEO as Dr. Han Ying transitions...
Xenon Reports Second Quarter 2025 Financial Results & Business Update
GlobeNewswire, Inc.
·
August 11, 2025
– Phase 3 azetukalner X-TOLE2 FOS study patient recruitment complete, with topline data anticipated in early 2026 – Phase 3 azetukalner neuropsychiatric studies underway with X-NOVA3 in MDD and X-CEED in BPD recently initiated – Phase 1 healthy...
Quest Resource Holding Corporation Reports Second Quarter 2025 Financial Results
GlobeNewswire, Inc.
·
August 11, 2025
Generated $3.9 million in operating cash flow in the second quarter and reduced debt by $6.6 million year to date Posted sequential improvements in gross profits and adjusted EBITDA Roll out of Operational Excellence Initiatives is on track and...
SLP BREAKING INVESTIGATION: BFA Law Announces an Investigation into Simulations Plus, Inc. after Stock Plummets over 25% on Impairment Charges – Contact BFA Law if You Lost Money
GlobeNewswire, Inc.
·
August 11, 2025
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the federal securities laws. If you invested in...
Oruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
·
August 11, 2025
First patients dosed in the EVERLAST-A Phase 2a trial of ORKA-001, with data expected in 2H 2026 ORKA-001 Phase 1 data and EVERLAST-A design to be presented at EADV in September 2025 ORKA-002 Phase 1 trial ongoing, with data to be presented around...
Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
·
August 11, 2025
- FDA approval of IDE to conduct a U.S. pilot study exploring the use of Alpha DaRT in patients with recurrent glioblastoma multiforme (GBM), a highly aggressive brain cancer - - Multiple U.S. clinical trials, including pancreatic cancer and GBM...
SCO Enhances UAE-China Trade, Economic Collaboration
MENAFN
·
August 11, 2025
(MENAFN) The Shanghai Cooperation Organization (SCO) is laying essential groundwork to enhance trade and economic collaboration between China and the United Arab Emirates (UAE), according to a leading business expert. “The majority of the trade...
US is at risk of cutting itself off from globalization due to imposed tariffs -UK economist
MENAFN
·
August 11, 2025
(MENAFN) A British economist has cautioned that by implementing tariffs globally, the United States risks isolating itself from the benefits of globalization, with the resulting price increases primarily affecting American shoppers. John Ross, a...
Lynch Carpenter Investigates Data Breach Claims in TeaOnHer Data Breach
GlobeNewswire, Inc.
·
August 11, 2025
PITTSBURGH, Aug. 11, 2025 (GLOBE NEWSWIRE) -- TeaOnHer recently announced a cybersecurity incident, which impacted the personal information of tens of thousands of individuals.¹ The information potentially impacted in the data breach includes...